Dendrimers in tissue engineering

dc.commentshttp://3bs.uminho.pt/node/20514por
dc.contributor.authorOliveira, Isabel Maria Lopes Matospor
dc.contributor.authorCarvalho, Mariana Rodriguespor
dc.contributor.authorReis, R. L.por
dc.contributor.authorOliveira, J. M.por
dc.date.accessioned2022-05-23T12:44:30Z
dc.date.available2022-05-23T12:44:30Z
dc.date.issued2021-04
dc.date.submitted2021-04
dc.date.updated2022-05-18T10:25:12Z
dc.description.abstractDendrimers are highly branched and multivalent, and monodispersive making them perfect candidates for a myriad of controlled drug delivery applications. Dendrimers possess many other advantages, such as the possibility of modulating surface chemistry and charge, and biodegradation rate and to be processed as scaffolds that can emulate natural extracellular matrices thus opening up unique applications in tissue engineering. The combination of dendrimers and other macromolecules (proteins and carbohydrates), as well as other traditional scaffold polymers, has led to the creation of hybrid scaffolds with new physical, mechanical, and biochemical properties. However, despite the widespread use of dendrimers in biomedical applications, their use in the fabrication of tissue engineering scaffolds remains some-how narrow. The most promising applications of dendritic macromolecules in TE area such as drug delivery strategies, cell differentiation and/or tissue regeneration, 3D/Dynamic platforms and ex vivo/in vivo testing are overviewed and discussed herein.por
dc.description.sponsorshipJMO for the financial support provided under the program “Investigador FCT” (IF/01285/2015). MCR acknowledges the IET Institution of Engineering and Technology for the financial support provided under the IET Harvey Research Prize 2017. IMO thanks the financial support under the Norte2020 project (“NORTE-08-5369-FSE-000044”).por
dc.distributioninternationalpor
dc.identifier.citationOliveira I. M., Carvalho M. R., Reis R. L., Oliveira J. M. Dendrimes in Tissue Engineering, Dendrimer-Based Nanotherapeutics, pp. 1-449, 978-0-12-821250-9, 2021por
dc.identifier.doi10.1016/B978-0-12-821250-9.00008-1por
dc.identifier.isbn978-0-12-821250-9por
dc.identifier.urihttps://hdl.handle.net/1822/77823
dc.language.isoengpor
dc.peerreviewedno
dc.publisherElsevierpor
dc.relationinfo:eu-repo/grantAgreement/FCT/Investigador FCT/IF%2F01285%2F2015%2FCP1294%2FCT0008/PTpor
dc.relation.publisherversionhttps://doi.org/10.1016/B978-0-12-821250-9.00008-1por
dc.rightsopenAccesspor
dc.subjectDendrimerspor
dc.subjectNanotherapeuticspor
dc.subjectNanoparticlespor
dc.subjectTissue engineeringpor
dc.subjectDrug deliverypor
dc.subjectMicrofluidicspor
dc.titleDendrimers in tissue engineeringpor
dc.typebookPartpor
dspace.entity.typePublicationen
oaire.citationEndPage336por
oaire.citationStartPage327por
sdum.bookTitleDendrimer-based nanotherapeuticspor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
20514-dendrimers-te-final-pdf.pdf
Tamanho:
1010.47 KB
Formato:
Adobe Portable Document Format